NO20064793L - Anvendelse av N-(2-arylpropionyl) sulfonamider for behandling av ryggmargskade. - Google Patents

Anvendelse av N-(2-arylpropionyl) sulfonamider for behandling av ryggmargskade.

Info

Publication number
NO20064793L
NO20064793L NO20064793A NO20064793A NO20064793L NO 20064793 L NO20064793 L NO 20064793L NO 20064793 A NO20064793 A NO 20064793A NO 20064793 A NO20064793 A NO 20064793A NO 20064793 L NO20064793 L NO 20064793L
Authority
NO
Norway
Prior art keywords
sulfonamides
treatment
spinal cord
cord injury
arylpropionyl
Prior art date
Application number
NO20064793A
Other languages
English (en)
Norwegian (no)
Inventor
Francesco Colotta
Riccardo Bertini
Original Assignee
Dompe Pha R Ma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Pha R Ma Spa filed Critical Dompe Pha R Ma Spa
Publication of NO20064793L publication Critical patent/NO20064793L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035Isoindoles, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20064793A 2004-03-25 2006-10-23 Anvendelse av N-(2-arylpropionyl) sulfonamider for behandling av ryggmargskade. NO20064793L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04007177A EP1579859B1 (fr) 2004-03-25 2004-03-25 Utilisation de N-(2-aryl-propionyl)-sulfonamides dans le traitement des lésions de la moelle épinière
PCT/EP2005/002822 WO2005092315A1 (fr) 2004-03-25 2005-03-17 Utilisation de n-(2-aryl-propionyl)-sulfonamides pour le traitement de lesions de la moelle epiniere

Publications (1)

Publication Number Publication Date
NO20064793L true NO20064793L (no) 2006-10-23

Family

ID=34854609

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064793A NO20064793L (no) 2004-03-25 2006-10-23 Anvendelse av N-(2-arylpropionyl) sulfonamider for behandling av ryggmargskade.

Country Status (23)

Country Link
US (1) US20090030083A1 (fr)
EP (1) EP1579859B1 (fr)
JP (1) JP4988550B2 (fr)
KR (2) KR101327150B1 (fr)
CN (2) CN1933825A (fr)
AT (1) ATE347883T1 (fr)
AU (1) AU2005226901B2 (fr)
BR (1) BRPI0509167A (fr)
CA (1) CA2555162C (fr)
CY (1) CY1107562T1 (fr)
DE (1) DE602004003673T2 (fr)
DK (1) DK1579859T3 (fr)
ES (1) ES2279248T3 (fr)
IL (1) IL177169A (fr)
MX (1) MXPA06009085A (fr)
NO (1) NO20064793L (fr)
NZ (1) NZ548917A (fr)
PL (1) PL1579859T3 (fr)
PT (1) PT1579859E (fr)
RU (1) RU2396075C2 (fr)
SI (1) SI1579859T1 (fr)
WO (1) WO2005092315A1 (fr)
ZA (1) ZA200608517B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090041753A1 (en) * 2006-09-26 2009-02-12 Miller Robert H Cytokine signaling
EP2308484A1 (fr) 2009-10-06 2011-04-13 Dompé S.p.a. Inhibiteurs de cxcr1/2 en tant qu'adjuvants pour la transplantation d'îlets pancréatiques
EP2308485A1 (fr) 2009-10-06 2011-04-13 Dompé S.p.a. Sulfonamides pour la prévention du diabète
CN103172547B (zh) * 2011-12-20 2016-10-12 天津市国际生物医药联合研究院 磺酰胺衍生物的制备及其应用
CN103159674A (zh) * 2013-04-03 2013-06-19 苏州安诺生物医药技术有限公司 2-苯烷酰胺类化合物及其制备方法、药物组合物和用途
KR20220064039A (ko) 2020-11-11 2022-05-18 정성삼 척수 손상 예방 또는 치료용 조성물
KR102320780B1 (ko) 2021-01-29 2021-11-02 정성삼 척추 통증 완화 및 척추 유연성 개선을 위한 조성물 및 이의 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303249B1 (it) * 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
US6419944B2 (en) * 1999-02-24 2002-07-16 Edward L. Tobinick Cytokine antagonists for the treatment of localized disorders
IT1318466B1 (it) * 2000-04-14 2003-08-25 Dompe Spa Ammidi di acidi r-2-(amminoaril)-propionici, utili nella prevenzionedell'attivazione leucocitaria.
ITMI20010206A1 (it) * 2001-02-02 2002-08-02 Dompe Spa Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz

Also Published As

Publication number Publication date
US20090030083A1 (en) 2009-01-29
CN103054842A (zh) 2013-04-24
JP2007530478A (ja) 2007-11-01
MXPA06009085A (es) 2007-04-02
DK1579859T3 (da) 2007-04-10
NZ548917A (en) 2010-06-25
EP1579859B1 (fr) 2006-12-13
CA2555162C (fr) 2012-11-27
EP1579859A1 (fr) 2005-09-28
PL1579859T3 (pl) 2007-06-29
WO2005092315A1 (fr) 2005-10-06
KR101327150B1 (ko) 2013-11-06
JP4988550B2 (ja) 2012-08-01
KR20120104445A (ko) 2012-09-20
CN1933825A (zh) 2007-03-21
KR101312235B1 (ko) 2013-09-26
IL177169A0 (en) 2006-12-10
DE602004003673D1 (de) 2007-01-25
AU2005226901A1 (en) 2005-10-06
ATE347883T1 (de) 2007-01-15
BRPI0509167A (pt) 2007-09-11
ES2279248T3 (es) 2007-08-16
ZA200608517B (en) 2008-04-30
AU2005226901B2 (en) 2011-06-02
KR20070018015A (ko) 2007-02-13
PT1579859E (pt) 2007-03-30
RU2006137575A (ru) 2008-04-27
DE602004003673T2 (de) 2007-10-04
SI1579859T1 (sl) 2007-04-30
CY1107562T1 (el) 2013-03-13
IL177169A (en) 2010-12-30
RU2396075C2 (ru) 2010-08-10
CA2555162A1 (fr) 2005-10-06

Similar Documents

Publication Publication Date Title
CY1110254T1 (el) Φαινυλακεταμιδια και χρησις των ως διαμορφωται γλυκοκινασης
EA200870446A1 (ru) Пиридон сульфонамиды и пиридон сульфамиды в качестве ингибиторов мек
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
CY1109414T1 (el) Ν-σουλφονυλ πυρρολια και χρηση αυτων ως αναστολεις αποακετυλασης ιστονης
EA200601587A1 (ru) Новые амидозамещённые гидрокси-6-фенилфенантридины
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
EA201000494A1 (ru) Новые гидрокси-8-гетероарилфенантридины и их применение в качестве ингибиторов pde4
BRPI0514586A (pt) triazolftalazinas
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
EA201000550A1 (ru) Производные тиазола
EA200700400A1 (ru) Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
NO20064415L (no) Nye amido-substituerte hydroksy-6-fenylfenantridiner og deres anvendelse som PDE4-inhibitorer
NO20064793L (no) Anvendelse av N-(2-arylpropionyl) sulfonamider for behandling av ryggmargskade.
EA200801351A1 (ru) Фунгицидные смеси, которые содержат боскалид и пириметанил
ATE477256T1 (de) Thienylverbindungen
EA201270630A1 (ru) Гетероциклические сетр ингибиторы
EA200601855A1 (ru) Гербицидоактивные 3-амино-2-тиометилбензоилпиразолы
EA200602281A1 (ru) Гетероарилсульфоны и сульфонамиды и их терапевтические применения
EA201000618A1 (ru) 5-цианотиенопиридины для лечения опухолей
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
ATE396970T1 (de) 2-(1h-indolylsulfanyl)-benzylaminderivate als ssri
CY1111432T1 (el) Τετραϋδροκινολινες για χρηση ως διαμορφωτες της μιτοτικης κινητικης πρωτεϊνης eg5
EA200602154A1 (ru) Пиридин-4-илэтинилимидазолы и -пиразолы как антагонисты рецептора mglu5
UY28344A1 (es) Nuevos compuestos
EA200901179A1 (ru) Замещённые тетрагидрохинолины

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application